Induction of antibodies binding to the membrane proximal external region of gp36 of HIV-2

Intervirology

Volumn 55, Issue 3, 2012, Pages 252-256

  Behrendt, R ^a   Fiebig, U ^a   Kurth, R ^a   Denner, J ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

HIV 2; Neutralizing antibodies; Transmembrane envelope protein; Vaccine

Indexed keywords

GLYCOPROTEIN 36; GLYCOPROTEIN 41; MONOCLONAL ANTIBODY 4E10; NEUTRALIZING ANTIBODY; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; EPITOPE MAPPING; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; IMMUNIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; RAT; SERODIAGNOSIS; VIRUS ENVELOPE; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; HIV ANTIBODIES; HIV-2; NEUTRALIZATION TESTS; RATS; VIRAL STRUCTURAL PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; RATTUS;

EID: 84857923474     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000324483     Document Type: Article

References (20)

1. Muster T, Steindl F, Purtscher M, Trkola A, Klima A, Himmler G, Rüker F, Katinger H: A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J Virol 1993; 67: 6642-6647. (Pubitemid 23309131)
2. Stiegler G, Kunert R, Purtscher M, Wolbank S, Voglauer R, Steindl F, Katinger H: A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type. AIDS Res Hum Retroviruses 2001; 10: 1757-1765. (Pubitemid 34114213)
3. Zwick MB, Labrijn AF, Wang M, Spenlehauer C, Saphire EO, Binley JM, Moore JP, Stiegler G, Katinger H, Burton DR, Parren PW: Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J Virol 2001; 75: 10892-10905. (Pubitemid 33034579)
4. Binley JM, Wrin T, Korber B, Zwick MB, Wang M, Chappey C, Stiegler G, Kunert R, Zolla-Pazner S, Katinger H, Petropoulos CJ, Burton DR: Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J Virol 2004; 78: 13232-13252. (Pubitemid 39507829)
5. Gaschen B, Taylor J, Yusim K, Foley B, Gao F, Lang D, Novitsky V, Haynes B, Hahn BH, Bhattacharya T, Korber B: Diversity considerations in HIV-1 vaccine selection. Science 2002; 296: 2354-2360. (Pubitemid 34734202)
6. Montero M, van Houten NE, Wang X, Scott JK: The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design. Microbiol Mol Biol Rev 2008; 72: 54-84. (Pubitemid 351398055)
7. Fiebig U, Stephan O, Kurth R, Denner J: Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation? Virology 2003; 307: 406-413.
8. Langhammer S, Fiebig U, Kurth R, Denner J: Neutralising antibodies against the transmembrane protein of feline leukaemia virus (FeLV). Vaccine 2005; 23: 3341-3348. (Pubitemid 40523129)
9. Langhammer S, Hubner J, Kurth R, Denner J: Antibodies neutralizing feline leukaemia virus (FeLV) in cats immunized with the transmembrane envelope protein p15E. Immunology 2006; 117: 229-237.
10. Fiebig U, Hartmann MG, Bannert N, Kurth R, Denner J: Transspecies transmission of the endogenous koala retrovirus. J Virol 2006; 80: 5651-5654.
11. Fiebig U, Schmolke M, Eschricht M, Kurth R, Denner J: Mode of interaction between the HIV-1-neutralizing monoclonal antibody 2F5 and its epitope. AIDS 2009; 23: 887-895.
12. Noah E, Biron Z, Naider F, Arshava B, Anglister J: The membrane proximal external region of the HIV-1 envelope glycoprotein gp41 contributes to the stabilization of the six-helix bundle formed with a matching N' peptide. Biochemistry 2008; 47: 6782-6792. (Pubitemid 351898933)
13. Bellamy-McIntyre AK, Lay CS, Baar S, Maerz AL, Talbo GH, Drummer HE, Poumbourios P: Functional links between the fusion peptide-proximal polar segment and membrane-proximal region of human immunodeficiency virus gp41 in distinct phases of membrane fusion. J Biol Chem 2007; 282: 23104-23116. (Pubitemid 47311910)
14. Buzon V, Natrajan G, Schibli D, Campelo F, Kozlov MM, Weissenhorn W: Crystal structure of HIV-1 gp41 including both fusion peptide and membrane proximal external regions. PLoS Pathog 2010; 6:e1000880.
15. Skott P, Achour A, Norin M, Thorstensson R, Bjorling E: Characterization of neutralizing sites in the second variable and fourth variable region in gp125 and a conserved region in gp36 of human immunodeficiency virus type. Viral Immunol 1999; 373: 72-84.
16. Tacke SJ, Bodusch K, Berg A, Denner J: Sensitive and specific immunological detection methods for porcine endogenous retroviruses applicable to experimental and clinical xenotransplantation. Xenotransplantation 2001; 8: 125-135. (Pubitemid 32336222)
17. Behrendt R, Fiebig U, Norley S, Gurtler L, Kurth R, Denner J: A neutralization assay for HIV-2 based on measurement of provirus integration by duplex real-time PCR. J Virol Methods 2009; 159: 40-46.
18. Gao F, Yue L, Robertson DL, Hill SC, Hui H, Biggar RJ, Neequaye AE, Whelan TM, Ho DD, Shaw GM: Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. J Virol 1994; 68: 7433-7447. (Pubitemid 24328799)
19. Mühle M, Bleiholder A, Kolb S, Hübner J, Löchelt M, Denner J: Immunological properties of the transmembrane envelope protein of the feline foamy virus and its use for serological screening. Virology 2011, Feb 10 [Epub ahead of print].
20. Lizeng Q, Skott P, Sourial S, Nilsson C, Andersson S S, Ehnlund M, Taveira N, Björling E: Serum immunoglobulin A (IgA)-mediated immunity in human immunodeficiency virus type 2 (HIV-2) infection. Virology 2003; 308: 225-232. (Pubitemid 36434230)